3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
Carboplatin
129
pembrolizumab
124
Cisplatin
114
Paclitaxel
103
Gemcitabine
84
Specimen Handling
81
Magnetic Resonance Spectroscopy
81
Docetaxel
71
Dexamethasone
61
Cyclophosphamide
61
Pemetrexed
55
Bevacizumab
55
durvalumab
53
Doxorubicin
53
Radiotherapy
50
Radiation
49
Capecitabine
48
Oxaliplatin
47
Fluorouracil
47
Vincristine
43
Rituximab
43
Leucovorin
42
Lenalidomide
40
Nivolumab
38
Etoposide
38
atezolizumab
35
Letrozole
35
Prednisone
32
Bortezomib
32
Irinotecan
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Association
×
90 days
×
Clear all
NCT01613482
2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3
Terminated
13 enrolled